Clinical Trials Directory

Trials / Completed

CompletedNCT03998462

Mindfulness Based Stress Reduction for Parkinson's Disease: A Longitudinal Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
107 (actual)
Sponsor
VA Office of Research and Development · Federal
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

To investigate the efficacy of Mindfulness-based Stress Reduction (MBSR) to improve quality of life, cognition, and mood, as well as to determine the longevity of the treatment response in individuals with Parkinson's disease (PD).

Detailed description

Eligible study participants with PD were randomly assigned to one of two 9-week remote (online) interventions: 1) Mindfulness Based Stress Reduction (MBSR) or 2) Psychoeducational Supportive Care (PSC). Intervention groups consisted of approximately 6-9 individuals and met weekly for 2.5 hours x 8 weeks and for 4 hours ("retreat") during week 7. All participants were remotely administered a battery of neuropsychological tests to measure quality of life, cognition (e.g., executive function, attention, memory), and mood (i.e., anxiety, depression, and apathy), as well as motor symptoms, disease severity, and mindfulness engagement/practice at pre-intervention (baseline), post-intervention (9 weeks), and at 6- and 12-months (follow-up assessments).

Conditions

Interventions

TypeNameDescription
BEHAVIORALMindfulness Based Stress ReductionMBSR used in this trial was based on the standard program developed by Jon Kabat-Zinn (1990). It consisted of weekly 2.5 hours sessions x 8 weeks and one 4-hour retreat during week 7. Due to the COVID-19 pandemic, the MBSR sessions were conducted completely online with randomized groups of 6-9 individuals with PD and were led by a trained instructor who was not involved in the clinical care or assessment of the participants.
BEHAVIORALPsychoeducational Supportive CarePSC is a novel intervention developed by Schiehser and colleagues to provide psychoeducation about Parkinson's disease and supportive group care. PSC consisted of weekly 2.5 hours sessions x 8 weeks and one 4-hour "retreat" during week 7. Due to the COVID-19 pandemic, all sessions were conducted completely online with randomized groups of 6-9 individuals with PD and were led by a trained instructor who was not involved in the clinical care or assessment of the participants.

Timeline

Start date
2020-01-01
Primary completion
2024-11-01
Completion
2024-11-01
First posted
2019-06-26
Last updated
2025-11-18
Results posted
2025-11-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03998462. Inclusion in this directory is not an endorsement.